Two new products added to the HRT PPC medicines list from June 2023

From June 2023, the Department of Health and Social Care (DHSC) has updated its definition of Hormone Replacement Therapy to include two more products to the list of HRT medicines covered by the new HRT prepayment certificate (HRT PPC). The new additions include: Tibolone 2.5mg tablets (Livial®) Prasterone 6.5mg pessaries (Intrarosa®) The June 2023 Drug Tariff (Part XVI) [...]

The post Two new products added to the HRT PPC medicines list from June 2023 appeared first on Community Pharmacy England.